MuReva Phototherapy has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant by the  National Institutes of Health (NIH) to continue development of…

Lumitex spins out a new company, MuReva Phototherapy Inc., based on project initiated by Vedang Kothari, who has been appointed as the new company’s President and CEO. The company will…

Vedang Kothari, President and CEO of MuReva Phototherapy, has been named to Crain’s Cleveland Business’ 2019 list of “Twenty in their 20s”. This list of individuals, which includes active, driven…

  MuReva Phototherapy has announced that the company has completed the National Institutes of Health (NIH) Commercialization Accelerator Program (CAP) which is only available for Phase II SBIR & STTR…

  MuReva Phototherapy has announced that the company has initiated a prospective, multi-center, randomized, double-blind, and placebo controlled pivotal clinical study. This study is designed to evaluate the safety and…

  MuReva Phototherapy announced that the company won the KJK Venture Pitch competition that was held during the Cleveland Smart Business Dealmakers Conference held on September 2, 2020. The annual…

  MuReva Phototherapy has announced that the Angel Physicians Fund has made an investment in the company and in conjunction with this investment, Manish Bhandari, MD, E-MBA will join the…

  MuReva Phototherapy announced today that they have been selected as one of the 2022 “Cool Companies” by Connect, a San Diego-based organization that helps promote top technology and life…

  As a result of being selected as a  2022 “Cool Company” by Connect, a San Diego-based organization that helps promote top technology and life sciences startups for funding, MuReva…

MuReva Phototherapy presented data from a pilot trial incorporating the us a the company’s LED=based intraoral Photobiomodulation (PBM) device for daily use in head and neck cancer patients undergoing radiation…